NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is notifying investors that a class action lawsuit has been filed against Medtronic plc (“Medtronic” or the “Company”) MDT and certain of its officers on behalf of all persons and entities that purchased or otherwise acquired Medtronic securities between June 8, 2019 and May 25, 2022, both dates inclusive (the “Collection Period”). Such investors are encouraged to join this case by visiting the company’s website: www.bgandg.com/mdt.

This class action seeks damages against the defendants for alleged violations of federal securities laws.

The Complaint filed in this Class Action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose the following: (1) Medtronic’s product quality control systems were inadequate; (2) Medtronic had failed to comply with numerous regulations related to risk assessment, corrective and preventive actions, complaint handling, device recalls, and adverse event reporting; (3) these errors increased the risk of regulatory investigations and actions; (4) due to the company’s misconduct, the US Food and Drug Administration (“FDA”) would delay approval of other Medtronic MiniMed devices, including the MiniMed 780G; (5) these product approval delays and the Company’s need to improve its quality control systems would adversely affect Medtronic’s financial performance and cause it to continue to lag behind its competitors; and (6) as a result of the foregoing, the statements made by defendants regarding the Company’s business, operations and prospects were unfounded. As the true details emerged, the lawsuit alleges that investors suffered damage.

A class action lawsuit has already been filed. If you would like to see a copy of the complaint, you can visit the firm’s website: www.bgandg.com/mdt or you can Peretz Bronstein, Esq. or his…